JP2015163632A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015163632A5 JP2015163632A5 JP2015096257A JP2015096257A JP2015163632A5 JP 2015163632 A5 JP2015163632 A5 JP 2015163632A5 JP 2015096257 A JP2015096257 A JP 2015096257A JP 2015096257 A JP2015096257 A JP 2015096257A JP 2015163632 A5 JP2015163632 A5 JP 2015163632A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- heteroaryl
- alkylene
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 14
- 125000000623 heterocyclic group Chemical group 0.000 claims 13
- 229910052757 nitrogen Inorganic materials 0.000 claims 10
- 125000006573 (C1-C10) heteroaryl group Chemical group 0.000 claims 8
- -1 —N (R a ) (R b ) Chemical class 0.000 claims 8
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 5
- 125000000041 C6-C10 aryl group Chemical group 0.000 claims 5
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 5
- 125000002993 cycloalkylene group Chemical group 0.000 claims 5
- 229910052805 deuterium Inorganic materials 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 4
- 125000005724 cycloalkenylene group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000006585 (C6-C10) arylene group Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 125000005549 heteroarylene group Chemical group 0.000 claims 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 2
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 2
- 125000006590 (C2-C6) alkenylene group Chemical group 0.000 claims 2
- 125000006591 (C2-C6) alkynylene group Chemical group 0.000 claims 2
- 125000006586 (C3-C10) cycloalkylene group Chemical group 0.000 claims 2
- 125000006553 (C3-C8) cycloalkenyl group Chemical group 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000006832 (C1-C10) alkylene group Chemical group 0.000 claims 1
- 125000006694 (C2-C10) heterocyclyl group Chemical group 0.000 claims 1
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims 1
- 125000004450 alkenylene group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000004419 alkynylene group Chemical group 0.000 claims 1
- 230000000975 bioactive effect Effects 0.000 claims 1
- 239000002207 metabolite Substances 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 229940002612 prodrug Drugs 0.000 claims 1
- 239000000651 prodrug Substances 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13160208P | 2008-06-10 | 2008-06-10 | |
| US13159908P | 2008-06-10 | 2008-06-10 | |
| US61/131,599 | 2008-06-10 | ||
| US61/131,602 | 2008-06-10 | ||
| US19015908P | 2008-08-26 | 2008-08-26 | |
| US61/190,159 | 2008-08-26 | ||
| US20106408P | 2008-12-05 | 2008-12-05 | |
| US61/201,064 | 2008-12-05 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011513627A Division JP5748659B2 (ja) | 2008-06-10 | 2009-06-09 | 新規な三環式化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015163632A JP2015163632A (ja) | 2015-09-10 |
| JP2015163632A5 true JP2015163632A5 (enExample) | 2016-02-18 |
Family
ID=41415363
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011513627A Active JP5748659B2 (ja) | 2008-06-10 | 2009-06-09 | 新規な三環式化合物 |
| JP2015096257A Pending JP2015163632A (ja) | 2008-06-10 | 2015-05-11 | 新規な三環式化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011513627A Active JP5748659B2 (ja) | 2008-06-10 | 2009-06-09 | 新規な三環式化合物 |
Country Status (36)
Families Citing this family (76)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3000973A1 (en) | 2008-06-10 | 2009-12-17 | Abbvie Inc. | Tricyclic compounds |
| US20120034250A1 (en) * | 2009-04-14 | 2012-02-09 | Astellas Pharma Inc. | Condensed pyrrolopyridine derivative |
| ES2552805T3 (es) | 2009-04-20 | 2015-12-02 | Auspex Pharmaceuticals, Llc | Inhibidores piperidínicos de la cinasa Janus 3 |
| WO2011011594A2 (en) * | 2009-07-23 | 2011-01-27 | Shriners Hospitals For Children | Intracellular toll-like receptors pathways and axonal degeneration |
| US8361962B2 (en) * | 2009-07-27 | 2013-01-29 | Roche Palo Alto Llc | Tricyclic inhibitors of JAK |
| EP2475667A1 (en) | 2009-09-10 | 2012-07-18 | F. Hoffmann-La Roche AG | Inhibitors of jak |
| ES2509590T3 (es) | 2009-09-21 | 2014-10-17 | F. Hoffmann-La Roche Ag | Inhibidores macrocíclicos de JAK |
| KR20130036171A (ko) | 2009-10-29 | 2013-04-11 | 브리스톨-마이어스 스큅 컴퍼니 | 트리시클릭 헤테로시클릭 화합물 |
| MX2012006381A (es) * | 2009-12-01 | 2012-06-19 | Abbott Lab | Nuevos compuestos triciclicos. |
| TW201802091A (zh) | 2009-12-01 | 2018-01-16 | 艾伯維有限公司 | 新穎三環化合物 |
| US8329705B2 (en) | 2009-12-30 | 2012-12-11 | Arqule, Inc. | Substituted triazolo-pyrazine compounds |
| CN102712640A (zh) * | 2010-01-12 | 2012-10-03 | 弗·哈夫曼-拉罗切有限公司 | 三环杂环化合物、其组合物和应用方法 |
| WO2011156698A2 (en) | 2010-06-11 | 2011-12-15 | Abbott Laboratories | NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS |
| DE102011106849A1 (de) * | 2010-12-15 | 2012-06-21 | Merck Patent Gmbh | Verfahren zur Synthese N-N verknüpfter und um die N-N Bindung rotationsgehinderter bis-N-heterocyclische Carbene und deren Einsatz als Liganden für Metallkomplexe |
| TW201309639A (zh) * | 2011-02-17 | 2013-03-01 | Lg Life Sciences Ltd | 作為ｇｐｒ１１９促效劑之肟衍生物 |
| WO2012127506A1 (en) * | 2011-03-22 | 2012-09-27 | Advinus Therapeutics Limited | Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| SG194216A1 (en) * | 2011-04-21 | 2013-11-29 | Origenis Gmbh | Heterocyclic compounds as kinase inhibitors |
| WO2012149280A2 (en) * | 2011-04-29 | 2012-11-01 | Abbott Laboratories | Novel tricyclic compounds |
| AR086113A1 (es) | 2011-04-30 | 2013-11-20 | Abbott Lab | Isoxazolinas como agentes terapeuticos |
| WO2013007768A1 (en) * | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors |
| RU2632870C2 (ru) | 2011-08-12 | 2017-10-11 | Ниссан Кемикал Индастриз, Лтд. | Трициклические гетероциклические соединения и ингибиторы jak |
| JP6220786B2 (ja) | 2012-07-19 | 2017-10-25 | 大日本住友製薬株式会社 | １−（シクロアルキルカルボニル）プロリン誘導体 |
| HK1206728A1 (en) | 2012-09-17 | 2016-01-15 | AbbVie Deutschland GmbH & Co. KG | Novel inhibitor compounds of phosphodiesterase type 10a |
| IN2015DN02008A (enExample) * | 2012-09-21 | 2015-08-14 | Advinus Therapeutics Ltd | |
| US10000482B2 (en) | 2012-10-19 | 2018-06-19 | Origenis Gmbh | Kinase inhibitors |
| CN102961382B (zh) * | 2012-11-28 | 2014-07-16 | 玉林师范学院 | 一种骨肉瘤细胞抑制剂及制备方法 |
| WO2014123167A1 (ja) | 2013-02-08 | 2014-08-14 | 日産化学工業株式会社 | ３環性ピロロピリジン化合物及びｊａｋ阻害剤 |
| JP2016135742A (ja) * | 2013-03-29 | 2016-07-28 | 日本農薬株式会社 | 縮合複素環化合物又はその塩類及び該化合物を含有する農園芸用殺虫剤並びにその使用方法 |
| WO2014169473A1 (en) * | 2013-04-19 | 2014-10-23 | Abbvie Inc. | 6H-IMIDAZO[1,5-a]PYRROLO[2,3-e]PYRAZINE COMPOUNDS |
| AU2014306759B2 (en) | 2013-08-12 | 2018-04-26 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
| CN103694168B (zh) * | 2013-12-05 | 2015-08-19 | 贵州威顿晶磷电子材料股份有限公司 | 一种6-氯-4-三氟甲基-3-氰基吡啶的制备方法 |
| US10172797B2 (en) | 2013-12-17 | 2019-01-08 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
| CA2944433A1 (en) | 2014-05-14 | 2015-11-19 | Nissan Chemical Industries, Ltd. | Tricyclic compound and jak inhibitor |
| ES2809458T3 (es) | 2014-07-17 | 2021-03-04 | Pharmaceutical Manufacturing Res Services Inc | Forma de dosificación llena de líquido, disuasoria del abuso y de liberación inmediata |
| EP3185852A1 (en) * | 2014-08-27 | 2017-07-05 | AbbVie Inc. | Topical formulation |
| WO2016064873A1 (en) | 2014-10-20 | 2016-04-28 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
| US10457677B2 (en) | 2015-04-02 | 2019-10-29 | Merck Patent Gmbh | Imidazolonylquinolines and the use thereof as ATM kinase inhibitors |
| US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| CN120478294A (zh) | 2015-10-16 | 2025-08-15 | 艾伯维公司 | 制备咪唑并[1,2-a]吡咯并[2,3-e]吡嗪类化合物及其固态形式的方法 |
| US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US12365689B2 (en) | 2015-10-16 | 2025-07-22 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11780848B2 (en) | 2015-10-16 | 2023-10-10 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof |
| US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| MD3419978T2 (ro) | 2016-02-24 | 2020-07-31 | Pfizer | Derivaţi de pirazolo[1,5-a]pirazin-4-il |
| EP3433615A1 (en) | 2016-03-21 | 2019-01-30 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Methods for diagnosis and treatment of solar lentigo |
| JOP20190060A1 (ar) | 2016-09-26 | 2019-03-26 | Chugai Pharmaceutical Co Ltd | مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1 |
| JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| RS63500B1 (sr) | 2016-12-16 | 2022-09-30 | Janssen Pharmaceutica Nv | Jedinjenja imidazo[4,5-d]pirolo[2,3-b]piridina kao inhibitori janus kinaza |
| US11564922B2 (en) | 2017-03-09 | 2023-01-31 | Abbvie Inc. | Methods of treating crohn's disease and ulcerative colitis |
| AU2018230500B2 (en) | 2017-03-09 | 2024-03-07 | Abbvie Inc. | Methods of treating Crohn's disease and ulcerative colitis |
| WO2018167283A1 (en) | 2017-03-17 | 2018-09-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma associated neural remodeling |
| WO2019034973A1 (en) | 2017-08-14 | 2019-02-21 | Pfizer Inc. | PYRAZOLO [1,5-A] PYRAZIN-4-YL AND RELATED DERIVATIVES |
| US11512067B2 (en) | 2017-09-14 | 2022-11-29 | Daiichi Sankyo Company, Limited | Compound having cyclic structure |
| WO2019100008A1 (en) * | 2017-11-20 | 2019-05-23 | Georgetown University | Treatments and methods for controlling hypertension |
| MX2020007010A (es) | 2018-01-05 | 2020-12-10 | Ottawa Hospital Res Inst | Vectores modificados de orthopoxvirus. |
| UY38144A (es) | 2018-03-12 | 2019-10-31 | Abbvie Inc | Inhibidores de la señalización mediada por tirosina cinasa |
| CN110294761B (zh) * | 2018-06-08 | 2020-09-08 | 南京雷正医药科技有限公司 | 作为Trk激酶抑制剂的取代的吡唑并[1,5-a]嘧啶化合物 |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| CN110872250B (zh) * | 2018-08-31 | 2023-01-10 | 苏州鹏旭医药科技有限公司 | 两种化合物及其制备方法和在合成乌西替尼中的用途 |
| EP4520395A3 (en) | 2018-11-01 | 2025-05-21 | Lynk Pharmaceuticals Co. Ltd. | Tricyclic janus kinase 1 inhibitors, and compositions and methods thereof |
| WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
| CN109369659B (zh) * | 2018-12-06 | 2020-10-27 | 浙江师范大学 | 一种jak抑制剂的合成方法 |
| EP4006028B1 (en) * | 2019-07-26 | 2025-07-02 | Zhuhai Yufan Biotechnologies Co., Ltd | Irak4 kinase inhibitor and preparation method therefor |
| CN110483514B (zh) * | 2019-09-16 | 2022-06-14 | 启元生物(杭州)有限公司 | 一种氰基取代的环肼衍生物及其应用 |
| CN113912535B (zh) * | 2020-07-07 | 2023-04-07 | 新发药业有限公司 | 一种6-氯-4-三氟甲基-3-氰基吡啶的制备方法 |
| CA3189037A1 (en) | 2020-07-08 | 2022-01-13 | Crystal Pharmaceutical (Suzhou) Co., Ltd. | Crystal form of upadacitinib, preparation method therefor, and use thereof |
| EP3944859A1 (en) | 2020-07-30 | 2022-02-02 | Assistance Publique Hôpitaux de Paris | Method for treating immune toxicities induced by immune checkpoint inhibitors |
| CN112028888B (zh) * | 2020-09-11 | 2021-08-20 | 中国药科大学 | 一种化合物及其制备方法和用途 |
| US20240108633A1 (en) * | 2020-12-29 | 2024-04-04 | Onquality Pharmaceuticals China Ltd. | Method for preventing or treating disease or condition associated with antitumor agent |
| AU2022233254A1 (en) | 2021-03-11 | 2023-10-26 | Janssen Pharmaceutica Nv | Lorpucitinib for use in the treatment of jak mediated disorders |
| CN113332298A (zh) * | 2021-05-27 | 2021-09-03 | 成都医学院 | 米诺环素作为酪氨酸激酶抑制剂的新用途 |
| CN113603693B (zh) * | 2021-07-13 | 2022-08-26 | 陕西丽彩药业有限公司 | 一种2-溴-5-对甲苯磺酰基-5H-吡咯并[2,3-b]吡嗪的制备方法 |
| WO2023194842A1 (en) | 2022-04-05 | 2023-10-12 | Unichem Laboratories Limited | Substituted tricyclic compounds and their use in rheumatoid arthritis |
| CN116947750A (zh) * | 2023-06-28 | 2023-10-27 | 北京民康百草医药科技有限公司 | 一种奈妥匹坦关键杂质的制备方法及检测方法 |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1376A (en) * | 1839-10-18 | Wateb-wheel | ||
| GB716327A (en) | 1951-09-05 | 1954-10-06 | Ici Ltd | New heterocyclic compounds |
| US3663559A (en) * | 1969-12-03 | 1972-05-16 | Union Carbide Corp | Preparation of oxo-furo-pyridines from furylvinyl isocyanates |
| ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
| US4053474A (en) * | 1976-04-21 | 1977-10-11 | E. R. Squibb & Sons, Inc. | Pyrazolo[4,3-e][1,2,4]triazolo[4,3-c]pyrimidine |
| US5605690A (en) | 1989-09-05 | 1997-02-25 | Immunex Corporation | Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
| CA2028235C (en) | 1989-10-20 | 1997-01-21 | Fumio Suzuki | Condensed purine derivatives |
| DE69133405T2 (de) | 1990-01-11 | 2005-07-07 | Isis Pharmaceutical, Inc., Carlsbad | Oligonukleotidderivate zur detektieren und modulation von rna aktivität und genexpression |
| US6262241B1 (en) * | 1990-08-13 | 2001-07-17 | Isis Pharmaceuticals, Inc. | Compound for detecting and modulating RNA activity and gene expression |
| EP1905782A1 (en) | 1991-03-18 | 2008-04-02 | New York University | Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| CA2110942A1 (en) | 1991-06-14 | 1992-12-23 | Pharmacia & Upjohn Company Llc | Imidazo¬1,5-a|quinoxalines |
| US5212310A (en) * | 1991-12-19 | 1993-05-18 | Neurogen Corporation | Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands |
| US5266698A (en) * | 1992-04-30 | 1993-11-30 | Neurogen Corporation | Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands |
| US5306819A (en) | 1992-08-27 | 1994-04-26 | Neurogen Corporation | Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands |
| WO1994011026A2 (en) | 1992-11-13 | 1994-05-26 | Idec Pharmaceuticals Corporation | Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| CN1118600A (zh) | 1993-02-26 | 1996-03-13 | 先灵公司 | 2-苄基-多环鸟嘌呤衍生物以及制备它们的方法 |
| US5736540A (en) * | 1993-07-29 | 1998-04-07 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| US5733905A (en) * | 1993-07-29 | 1998-03-31 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| IL112248A0 (en) | 1994-01-25 | 1995-03-30 | Warner Lambert Co | Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them |
| US5547975A (en) | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| RU2158127C2 (ru) | 1994-12-23 | 2000-10-27 | Варнер-Ламберт Компани | Способы ингибирования тирозинкиназы рецептора эпидермального фактора роста, азотсодержащие трициклические соединения, фармацевтическая композиция, предназначенная для введения ингибитора тирозинкиназы рецептора эпидермального фактора роста, например, erb-b2, erb-b3 или erb-b4, и противозачаточная композиция |
| US5521173A (en) * | 1995-01-17 | 1996-05-28 | American Home Products Corporation | Tricyclic benzazepine vasopressin antagonists |
| US5753648A (en) * | 1995-01-17 | 1998-05-19 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
| US5763137A (en) * | 1995-08-04 | 1998-06-09 | Agfa-Gevaert, N.V. | Method for making a lithographic printing plate |
| US6090382A (en) | 1996-02-09 | 2000-07-18 | Basf Aktiengesellschaft | Human antibodies that bind human TNFα |
| WO1999045009A1 (en) * | 1998-03-04 | 1999-09-10 | Bristol-Myers Squibb Company | Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| IL139197A0 (en) | 1999-10-29 | 2001-11-25 | Pfizer Prod Inc | Use of corticotropin releasing factor antagonists and related compositions |
| TWI271406B (en) * | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| MXPA03001186A (es) * | 2000-08-07 | 2004-04-20 | Neurogen Corp | Compuestos heterociclicos como ligandos del receptor acido gamma aminobutirico (gabaa). |
| GB0115393D0 (en) | 2001-06-23 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
| GB0124299D0 (en) | 2001-10-10 | 2001-11-28 | Astrazeneca Ab | Crystal structure of enzyme and uses thereof |
| ATE353013T1 (de) * | 2002-02-19 | 2007-02-15 | Pfizer Italia Srl | Trizyklische pyrazolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor mittel |
| TW200400034A (en) * | 2002-05-20 | 2004-01-01 | Bristol Myers Squibb Co | Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| MXPA05007503A (es) | 2003-01-17 | 2005-09-21 | Warner Lambert Co | Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular. |
| US7169926B1 (en) * | 2003-08-13 | 2007-01-30 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| US20060074102A1 (en) * | 2004-05-14 | 2006-04-06 | Kevin Cusack | Kinase inhibitors as therapeutic agents |
| PE20060526A1 (es) * | 2004-06-15 | 2006-07-13 | Schering Corp | Compuestos triciclicos como antagonistas de mglur1 |
| EP1773840B1 (de) | 2004-07-23 | 2010-01-20 | The Medicines Company (Leipzig) GmbH | Substituierte pyrido[3',2':4,5]thieno[3,2-d]pyrimidine und pyrido[3',2':4,5]furo[3,2-d]-pyrimidine zur verwendung als inhibitoren der pda-4 und/oder tnf-alpha freisetzung |
| WO2006074985A1 (en) | 2005-01-14 | 2006-07-20 | Janssen Pharmaceutica N.V. | 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| EP1844048B1 (en) | 2005-01-14 | 2010-05-26 | Janssen Pharmaceutica N.V. | Pyrazolopyrimidines as cell cycle kinase inhibitors |
| US20060183758A1 (en) * | 2005-02-17 | 2006-08-17 | Cb Research And Development, Inc. | Method for synthesis of AZA-annelated pyrroles, thiophenes, and furans |
| AU2006232294A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | Pyrazolo[3,4-c]quinolines, pyrazolo[3,4-c]naphthyridines, analogs thereof, and methods |
| US7737279B2 (en) | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
| US7593820B2 (en) * | 2005-05-12 | 2009-09-22 | Cytopia Research Pty Ltd | Crystal structure of human Janus Kinase 2 (JAK2) and uses thereof |
| CA2615291A1 (en) | 2005-07-14 | 2007-01-18 | Astellas Pharma Inc. | Heterocyclic janus kinase 3 inhibitors |
| CN102127078A (zh) * | 2005-07-14 | 2011-07-20 | 安斯泰来制药株式会社 | Janus激酶3的杂环类抑制剂 |
| EP1919924A2 (en) * | 2005-08-16 | 2008-05-14 | Irm, Llc | Compounds and compositions as protein kinase inhibitors |
| JP4551962B2 (ja) | 2005-09-23 | 2010-09-29 | コーリー ファーマシューティカル グループ，インコーポレイテッド | １Ｈ−イミダゾ［４，５−ｃ］ピリジンおよびその類似体のための方法 |
| EP1954290B1 (en) | 2005-11-22 | 2012-07-25 | Merck Sharp & Dohme Corp. | Tricyclic compounds useful as inhibitors of kinases |
| JP5512975B2 (ja) * | 2005-12-29 | 2014-06-04 | アッヴィ・インコーポレイテッド | タンパク質キナーゼ阻害薬 |
| JP5386350B2 (ja) | 2006-05-31 | 2014-01-15 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体 |
| US8063225B2 (en) | 2006-08-14 | 2011-11-22 | Chembridge Corporation | Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| CA2665214A1 (en) | 2006-10-06 | 2008-05-29 | Abbott Laboratories | Novel imidazothiazoles and imidazoxazoles |
| US20100105661A1 (en) | 2007-01-12 | 2010-04-29 | Astellas Pharma Inc. | Condensed pyridine compound |
| US20110281821A9 (en) | 2007-01-30 | 2011-11-17 | Biogen Idec Ma Inc. | Modulators of Mitotic Kinases |
| WO2008112695A2 (en) | 2007-03-12 | 2008-09-18 | Irm Llc | Pyrazolo [3,4-d] pyrimidines and 1, 2, 5, 6-tetraaza- as- indacenes as protein kinase inhibitors for cancer treatment |
| US7723343B2 (en) | 2007-03-30 | 2010-05-25 | King Pharmaceuticals Research And Development, Inc. | Adenosine A2A receptor antagonists |
| US8188083B2 (en) | 2007-06-28 | 2012-05-29 | Abbott Laboratories | Triazolopyridazines |
| AU2009218607B2 (en) * | 2008-02-25 | 2014-02-13 | F. Hoffmann-La Roche Ag | Pyrrolopyrazine kinase inhibitors |
| EP2247595B1 (en) * | 2008-02-25 | 2011-07-20 | F. Hoffmann-La Roche AG | Pyrrolopyrazine kinase inhibitors |
| CN101952294B (zh) * | 2008-02-25 | 2014-11-26 | 霍夫曼-拉罗奇有限公司 | 吡咯并吡嗪激酶抑制剂 |
| WO2009108827A1 (en) | 2008-02-29 | 2009-09-03 | Wyeth | Fused tricyclic pyrazolo[1, 5-a]pyrimidines, methods for preparation and uses thereof |
| CA3000973A1 (en) | 2008-06-10 | 2009-12-17 | Abbvie Inc. | Tricyclic compounds |
| CN102143746A (zh) | 2008-07-03 | 2011-08-03 | 埃克塞利希斯股份有限公司 | Cdk 调节剂 |
| US20120034250A1 (en) * | 2009-04-14 | 2012-02-09 | Astellas Pharma Inc. | Condensed pyrrolopyridine derivative |
| US8361962B2 (en) * | 2009-07-27 | 2013-01-29 | Roche Palo Alto Llc | Tricyclic inhibitors of JAK |
| TW201802091A (zh) * | 2009-12-01 | 2018-01-16 | 艾伯維有限公司 | 新穎三環化合物 |
| MX2012006381A (es) | 2009-12-01 | 2012-06-19 | Abbott Lab | Nuevos compuestos triciclicos. |
| WO2011156698A2 (en) * | 2010-06-11 | 2011-12-15 | Abbott Laboratories | NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS |
| WO2012149280A2 (en) * | 2011-04-29 | 2012-11-01 | Abbott Laboratories | Novel tricyclic compounds |
| WO2013043826A1 (en) * | 2011-09-21 | 2013-03-28 | Abbvie Inc. | Tricyclic compounds useful as protein kinase inhibitors |
-
2009
- 2009-06-09 CA CA3000973A patent/CA3000973A1/en not_active Abandoned
- 2009-06-09 SI SI200931347T patent/SI2299821T1/sl unknown
- 2009-06-09 KR KR1020167035162A patent/KR101718384B1/ko active Active
- 2009-06-09 HU HUE09763424A patent/HUE028347T2/en unknown
- 2009-06-09 PE PE2010001126A patent/PE20110223A1/es active IP Right Grant
- 2009-06-09 TW TW098119270A patent/TWI449703B/zh active
- 2009-06-09 DK DK09763424.0T patent/DK2299821T3/en active
- 2009-06-09 TW TW103118323A patent/TWI527819B/zh active
- 2009-06-09 WO PCT/US2009/046714 patent/WO2009152133A1/en not_active Ceased
- 2009-06-09 PT PT97634240T patent/PT2299821E/pt unknown
- 2009-06-09 RS RS20160062A patent/RS54560B1/sr unknown
- 2009-06-09 ES ES09763424.0T patent/ES2559403T3/es active Active
- 2009-06-09 MX MX2010013557A patent/MX2010013557A/es active IP Right Grant
- 2009-06-09 US US12/481,028 patent/US8962629B2/en active Active
- 2009-06-09 UY UY0001031881A patent/UY31881A/es not_active Application Discontinuation
- 2009-06-09 UA UAA201100242A patent/UA106045C2/uk unknown
- 2009-06-09 ME MEP-2016-72A patent/ME02340B/me unknown
- 2009-06-09 JP JP2011513627A patent/JP5748659B2/ja active Active
- 2009-06-09 CN CN201410747767.0A patent/CN104592231A/zh active Pending
- 2009-06-09 EP EP15192686.2A patent/EP3031324A3/en not_active Withdrawn
- 2009-06-09 MY MYPI2010005827A patent/MY161369A/en unknown
- 2009-06-09 KR KR1020117000497A patent/KR20110017431A/ko not_active Withdrawn
- 2009-06-09 TW TW104143241A patent/TW201612182A/zh unknown
- 2009-06-09 HR HRP20160098TT patent/HRP20160098T1/hr unknown
- 2009-06-09 EP EP09763424.0A patent/EP2299821B1/en active Active
- 2009-06-09 AU AU2009257602A patent/AU2009257602B2/en active Active
- 2009-06-09 CN CN2009801311819A patent/CN102118968A/zh active Pending
- 2009-06-09 RU RU2015105591/04A patent/RU2015105591A/ru not_active Application Discontinuation
- 2009-06-09 PE PE2013001090A patent/PE20140407A1/es not_active Application Discontinuation
- 2009-06-09 BR BRPI0915374-8A patent/BRPI0915374B1/pt active IP Right Grant
- 2009-06-09 RU RU2010153582/04A patent/RU2545023C9/ru active
- 2009-06-09 NZ NZ623922A patent/NZ623922A/en unknown
- 2009-06-09 PL PL09763424T patent/PL2299821T3/pl unknown
- 2009-06-09 CA CA2727032A patent/CA2727032C/en active Active
- 2009-06-10 AR ARP090102084A patent/AR072086A1/es active IP Right Grant
-
2010
- 2010-11-18 IL IL209434A patent/IL209434A0/en active IP Right Grant
- 2010-11-29 CO CO10150402A patent/CO6382083A2/es not_active Application Discontinuation
- 2010-11-29 ZA ZA2010/08562A patent/ZA201008562B/en unknown
- 2010-12-02 NO NO20101688A patent/NO20101688A1/no not_active Application Discontinuation
- 2010-12-03 EC EC2010010657A patent/ECSP10010657A/es unknown
- 2010-12-08 DO DO2010000382A patent/DOP2010000382A/es unknown
- 2010-12-10 CL CL2010001426A patent/CL2010001426A1/es unknown
-
2013
- 2013-03-08 DO DO2013000055A patent/DOP2013000055A/es unknown
-
2015
- 2015-01-30 US US14/610,119 patent/US9365579B2/en active Active
- 2015-05-11 JP JP2015096257A patent/JP2015163632A/ja active Pending
-
2016
- 2016-01-06 CR CR20160007A patent/CR20160007A/es unknown
- 2016-01-27 CY CY20161100074T patent/CY1117165T1/el unknown
- 2016-05-12 US US15/152,823 patent/US20160326181A1/en not_active Abandoned
-
2017
- 2017-11-07 US US15/806,104 patent/US20180291029A1/en not_active Abandoned
-
2022
- 2022-01-14 US US17/575,731 patent/US20230082167A1/en not_active Abandoned